AzTrials
AzTrials

Muscle Protein SynthesisNCT00653679

Exercise and Muscle Protein Signalling

A study testing exercise in people with Muscle Protein Synthesis, run by Maastricht University Medical Center at 1 site in Netherlands.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This study examines the muscle protein signalling response after resistance and endurance exercise. We hypothesize that the signalling response after endurance and resistance exercise will be partly similar. Read more about this study

Who is it for?
Ages 18 to 28 years, men onlyHealthy volunteers can take part
Conditions the study is for
Muscle Protein Synthesis
What is being tested?
exercise
How many people
0 participants
Where
1 siteNetherlands
Study dates
Sep 2008to Feb 2009
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 28 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • healthy men
  • inactive

Who cannot join

  • enrolled in a endurance and/or resistance training program

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Maastricht University

    Maastricht, Limburg, 6200 MD

Other trials in Netherlands

About this study

Official title: The Impact of Resistance Versus Endurance Exercise on the Muscle Protein Signalling Response

This study examines the muscle protein signalling response after resistance and endurance exercise. We hypothesize that the signalling response after endurance and resistance exercise will be partly similar.

Being tested
exercise
Keywords
exercise, muscle protein signalling, protein synthesis
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • exerciseOther

    1 hour of endurance or resistance exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The difference in phosphorylation of different signalling proteins in the cascade towards protein synthesis

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Apr 2008 (estimated)
  2. Study startSep 2008
  3. Primary completionFeb 2009 (estimated)
  4. Study completionFeb 2009 (estimated)

Why it stopped: A paper on the same topic came out just before we wanted to start our study.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00653679
Sponsor's protocol ID
MEC0001
Status last verified
Apr 2015
First submitted
1 Apr 2008
Last updated
14 Apr 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing exercise in people with Muscle Protein Synthesis, run by Maastricht University Medical Center at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 14 Apr 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The difference in phosphorylation of different signalling proteins in the cascade towards protein synthesis (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Apr 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in